Mixed fortunes for foreign-invested pharmaceutical firms in Korea

For the immediate future, foreign-invested pharmaceutical firms expect positive growth in Korea's overall pharmaceutical markers, thanks to substantial accumulation of retained earnings for the past years, but market analysts warn that these multinational firms would likely face increased competition, as major domestic firms are vigorously rushing to launch their first generic drugs in ...